Your Questions, Answered
We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
High Alert – 250 mg/dL
Low Alert – 65 mg/dL
High Target – 180 mg/dL
Low Target - 70 mg/dL
If the Eversense® 365 Smart Transmitter does not vibrate, try the following steps:
- Check that the smart transmitter is connected (paired) to your mobile device.
- Check that the Do Not Disturb is disabled by tapping Menu > Settings > Sound Settings.
- Check that your smart transmitter has enough battery power and charge if necessary.
- Go to About > My Transmitter and tap Demonstration.
If the smart transmitter still will not vibrate, contact Customer Service or your local distributor for further troubleshooting.
The sensor uses fluorescence to measure glucose in interstitial fluid. It is inserted under the skin and provides glucose readings for up to 1 year. The sensor uses a unique fluorescent, glucose indicating polymer to measure glucose concentration based on the changes in light.
The sensor is approximately 3.5 mm x 18.3 mm and contains a small amount of dexamethasone acetate, an anti-inflammatory steroid drug. The dexamethasone acetate minimizes inflammatory responses, very similar to pacemakers.
On the Main Menu, tap Connect or System Setup > Help me set up > I have a new transmitter. Tap and hold the name of your old smart transmitter. Tap OK to stop the app from automatically connecting with the old smart transmitter. Forget the old smart transmitter from your phone’s Bluetooth settings.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1
Call My Eversense Specialist Now
Schedule a Call